Target intelligence / Profile preview

Type 2 helper T cell (Th2 cell) (Th2 cell)

Target
Th2 cell
Molecular classification
Other
01

Overview

Type 2 helper T cells (Th2 cells) are a specialized subset of CD4+ T lymphocytes that coordinate the immune response against extracellular parasites and are the primary drivers of allergic inflammation (Galli et al., Nature, 2008). In the context of house dust mite (HDM) exposure, these cells are activated by allergens like Der p 1, leading to the secretion of a signature profile of cytokines, including interleukin-4 (IL-4), IL-5, and IL-13 (Gregory and Lloyd, Nature Reviews Immunology, 2011). These cytokines promote B-cell isotype switching to IgE, facilitate the recruitment and survival of eosinophils, and induce airway hyperresponsiveness and mucus hypersecretion. While essential for mucosal immunity, the dysregulation of Th2 cells in response to environmental allergens is central to the pathogenesis of allergic asthma and rhinitis (PubMed: 27510459). Therapeutic strategies generally do not target the Th2 cell itself for depletion but instead focus on neutralizing its effector cytokines or blocking their specific receptors to mitigate chronic inflammation (PubMed: 21738203).

Other names
Th2 effector T cellT-helper 2 cellCD4+ Type 2 T cellTh2 lymphocyte
02

Mechanism of action

Therapeutic agents target the Th2 pathway by neutralizing secreted cytokines (IL-4, IL-5, IL-13) or blocking their receptors (IL-4Ra, IL-5Ra, CRTH2) to inhibit the downstream inflammatory cascade (PubMed: 27510459; PubMed: 21738203).

03

Biological functions

Immune responseCytokine productionB cell activationEosinophil recruitmentOther
04

Disease associations

InflammationAllergic asthmaAtopic dermatitisAllergic rhinitisOther
05

Safety considerations

Increased risk of helminth infectionsInjection site reactionsHypersensitivity reactionsAnaphylaxis
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

Blood eosinophil countFractional exhaled nitric oxide (FeNO)Serum IgEPeriostin

Beyond the preview

Go deeper on Type 2 helper T cell (Th2 cell) (Th2 cell).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Type 2 helper T cell (Th2 cell) (Th2 cell).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call